1145 related articles for article (PubMed ID: 26423218)
21. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
Kim HK; Park TG
J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894
[TBL] [Abstract][Full Text] [Related]
22. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.
Yang YY; Chung TS; Ng NP
Biomaterials; 2001 Feb; 22(3):231-41. PubMed ID: 11197498
[TBL] [Abstract][Full Text] [Related]
23. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
Della Porta G; Reverchon E
Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
[TBL] [Abstract][Full Text] [Related]
24. Properties of multiphase microspheres of poly(dl-lactic acid) or poly(dl-lactic-co-glycolic acid) produced by mechanical agitation, sonication, or potentiometric dispersion.
O'Donnell PB; McGinity JW
J Microencapsul; 1996; 13(6):667-77. PubMed ID: 8933352
[TBL] [Abstract][Full Text] [Related]
25. Effect of solvent on drug release and a spray-coated matrix of a sirolimus-eluting stent coated with poly(lactic-co-glycolic acid).
Choi J; Jang BN; Park BJ; Joung YK; Han DK
Langmuir; 2014 Aug; 30(33):10098-106. PubMed ID: 25090045
[TBL] [Abstract][Full Text] [Related]
26. Quantitative three-dimensional analysis of poly (lactic-co-glycolic acid) microsphere using hard X-ray nano-tomography revealed correlation between structural parameters and drug burst release.
Huang X; Li N; Wang D; Luo Y; Wu Z; Guo Z; Jin Q; Liu Z; Huang Y; Zhang Y; Wu C
J Pharm Biomed Anal; 2015 Aug; 112():43-9. PubMed ID: 25951620
[TBL] [Abstract][Full Text] [Related]
27. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
28. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
[TBL] [Abstract][Full Text] [Related]
29. Poly (lactic-co-glycolic acid) particles prepared by microfluidics and conventional methods. Modulated particle size and rheology.
Perez A; Hernández R; Velasco D; Voicu D; Mijangos C
J Colloid Interface Sci; 2015 Mar; 441():90-7. PubMed ID: 25490568
[TBL] [Abstract][Full Text] [Related]
30. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
Keohane K; Brennan D; Galvin P; Griffin BT
Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
[TBL] [Abstract][Full Text] [Related]
31. Formulation of porous poly(lactic-co-glycolic acid) microparticles by electrospray deposition method for controlled drug release.
Hao S; Wang Y; Wang B; Deng J; Zhu L; Cao Y
Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():113-9. PubMed ID: 24863206
[TBL] [Abstract][Full Text] [Related]
32. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
Sinha VR; Trehan A
Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
[TBL] [Abstract][Full Text] [Related]
33. Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells.
Sahoo SK; Panda AK; Labhasetwar V
Biomacromolecules; 2005; 6(2):1132-9. PubMed ID: 15762686
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery.
Haddadi A; Farboud ES; Erfan M; Aboofazeli R
J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885
[TBL] [Abstract][Full Text] [Related]
35. Polymer based microspheres of aceclofenac as sustained release parenterals for prolonged anti-inflammatory effect.
Kaur M; Sharma S; Sinha VR
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():492-500. PubMed ID: 28024613
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres.
Xu FH; Zhang Q
Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799
[TBL] [Abstract][Full Text] [Related]
37. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
38. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Kranz H; Bodmeier R
Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
[TBL] [Abstract][Full Text] [Related]
39. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent.
Young TJ; Johnston KP; Mishima K; Tanaka H
J Pharm Sci; 1999 Jun; 88(6):640-50. PubMed ID: 10350502
[TBL] [Abstract][Full Text] [Related]
40. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine.
Thomas C; Rawat A; Hope-Weeks L; Ahsan F
Mol Pharm; 2011 Apr; 8(2):405-15. PubMed ID: 21189035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]